PIPERACILLIN/TAZOBACTAM MYLAN
4G/500MG INF PLV SOL 1
| SÚKL code | 0141263 |
|---|---|
| Name of the product | PIPERACILLIN/TAZOBACTAM MYLAN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | PIPERACILLIN/TAZOBACTAM MYLAN |
| Supplement | 4G/500MG INF PLV SOL 1 |
| Strenght | 4G/500MG |
| Pharmaceutical form | Powder for solution for infusion |
| Package | 1 |
| Route | Intravenous use |
| Language of the pack | Czech |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
PIPERACILLIN SODIUM (PIPERACILLINUM NATRICUM) TAZOBACTAM SODIUM (TAZOBACTAMUM NATRICUM) |
| ATC group | J01CR05 |
| ATC group name | PIPERACILIN A INHIBITOR BETA-LAKTAMASY |
Marketing authorisation information
| Registration Number | 15/ 740/09-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 03. 2022 |
| MA Holder | Mylan S.A.S., Saint-Priest |
| MA Holder country | FRANCIE |
| Actual MA holder | VIATRIS LIMITED, Dublin |
| Actual MA holder country | IRSKO |
cz